644 related articles for article (PubMed ID: 15458853)
1. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression.
Zimmerman M; Posternak MA; Chelminski I
J Psychiatr Res; 2004; 38(6):577-82. PubMed ID: 15458853
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
Heo M; Murphy CF; Meyers BS
Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
4. Implications of using different cut-offs on symptom severity scales to define remission from depression.
Zimmerman M; Posternak MA; Chelminski I
Int Clin Psychopharmacol; 2004 Jul; 19(4):215-20. PubMed ID: 15201568
[TBL] [Abstract][Full Text] [Related]
5. Defining remission on the Montgomery-Asberg depression rating scale.
Zimmerman M; Posternak MA; Chelminski I
J Clin Psychiatry; 2004 Feb; 65(2):163-8. PubMed ID: 15003068
[TBL] [Abstract][Full Text] [Related]
6. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
[TBL] [Abstract][Full Text] [Related]
7. Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?
Zimmerman M; Posternak MA; Chelminski I
J Nerv Ment Dis; 2005 Mar; 193(3):170-5. PubMed ID: 15729106
[TBL] [Abstract][Full Text] [Related]
8. An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder.
Hooper CL; Bakish D
J Psychiatry Neurosci; 2000 Mar; 25(2):178-84. PubMed ID: 10740991
[TBL] [Abstract][Full Text] [Related]
9. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
Boulenger JP; Huusom AK; Florea I; Baekdal T; Sarchiapone M
Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
[TBL] [Abstract][Full Text] [Related]
11. Validity of a self-report depression symptom scale for identifying remission in depressed outpatients.
Zimmerman M; Posternak MA; McGlinchey J; Friedman M; Attiullah N; Boerescu D
Compr Psychiatry; 2006; 47(3):185-8. PubMed ID: 16635646
[TBL] [Abstract][Full Text] [Related]
12. The Montgomery-Asberg Depression Rating Scale and the Cornell Scale for Depression in Dementia: a validation study with patients exhibiting early-onset dementia.
Leontjevas R; van Hooren S; Mulders A
Am J Geriatr Psychiatry; 2009 Jan; 17(1):56-64. PubMed ID: 19092312
[TBL] [Abstract][Full Text] [Related]
13. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
15. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
16. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
[TBL] [Abstract][Full Text] [Related]
18. Standardized clinical outcome rating scale for depression for use in clinical practice.
Zimmerman M; Posternak MA; Chelminski I; Friedman M
Depress Anxiety; 2005; 22(1):36-40. PubMed ID: 15799015
[TBL] [Abstract][Full Text] [Related]
19. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
[TBL] [Abstract][Full Text] [Related]
20. The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice.
van der Lem R; van der Wee NJ; van Veen T; Zitman FG
Psychol Med; 2011 Jul; 41(7):1353-63. PubMed ID: 21078225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
